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ABSTRACT
Background and aim: Education of patients with ulcerative 
colitis (UC) about their disease and access to a specialist are 
important to improve health outcomes. Our objective was to 
determine, by collecting information directly from the patients, their 
information sources and knowledge of the disease, and the options 
for access to the gastroenterologist.
Methods: The information was collected using a printed 
survey handed out by 39 gastroenterologists to 15 consecutive 
adult patients with UC. Patients answered anonymously from their 
home. The responses were stratified by hospital size (> 900; 500-
900; < 500 beds).
Results: A total of 585 patients received the survey and 436 
responded (74.5%; mean age of 46 years [13.5], 53% men). The 
main information source was the specialist physician (89.2%). 
Between 32% and 80% of patients had areas of improvement 
regarding knowledge of their disease. Knowledge of the disease 
was better in patients from small hospitals (< 500 beds). The 
frequency of routine visits was also higher in small hospitals. In 
case of a flare-up, 60% stated they were able to contact their 
doctor by phone and 37%, that they could get an appointment 
on the same day. The percentage stating that they had to ask for 
an appointment and wait until their physician was available was 
lower in small hospitals.
Conclusions: There are areas of improvement with regard to 
knowledge of their disease in patients with UC followed in hospital 
clinics. Patients followed in small hospitals seem to know their 
disease better, are followed more frequently in the clinic, and have 
better access in case of a flare-up. 
Key words: Ulcerative colitis. Self-management. Information 
sources. Knowledge of disease. Access to physician.
INTRODUCTION
Ulcerative colitis (UC) is a chronic inflammatory bow-
el disease of unknown cause in which both genetic and 
environmental factors are involved. The rectal mucosa is 
always affected, and extension, which is always continu-
ous from the rectum and in the proximal direction, varies 
from patients with rectal involvement only (proctitis) to 
patients with disease in the entire colon (1,2).
The chronic relapsing nature of UC, its socially stig-
matizing symptoms, and its most common onset in the 
second decade of life trigger profound changes in the life 
of patients from the time of diagnosis (3,4). Added to the 
physical impact of the symptoms are the effects on the 
patient psyche from the impact of the disease on social, 
work and emotional relationships, which eventually leads 
to impaired quality of life of these patients (5-9).
All the above justifies why patient-physician commu-
nication is a vital element in the care process of these 
patients, where the construction of collaborative relation-
ships between both becomes a key element to achieve opti-
mal management of the disease (10,11). Efficient physi-
cian-patient communication contributes to the achievement 
of better health outcomes and has been significantly asso-
ciated with better treatment adherence (12-14). 
An adequate knowledge of the disease by UC patients 
will enable them to better face their disease and the pos-
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sibilities for self-management. Two especially sensitive 
periods for the patient when the need for information and/
or education is greatest are after diagnosis and at the time 
of relapse (15). The most relevant areas of information for 
patients after diagnosis are related to symptoms, possible 
complications, etiology, long-term course, risk of cancer, 
and the impact of the disease and treatments on fertility 
(11). 
The UC-LIFE survey was conducted in a large sam-
ple of UC patients followed in hospital throughout Spain 
in order to determine their perceptions, points of view 
and opinions on the experience of living with UC. The 
description of the survey and the results on the perception 
of the symptom burden and emotional impact of the dis-
ease have been previously published (16,17). The objective 
of this study was to determine, by collecting information 
directly from UC patients, their information sources and 
knowledge of the disease and the ease with which they 
can access the gastroenterologist (frequency of visits to a 
specialist and options for contacting the specialist in case 
of a flare-up).
METHODS
UC-LIFE was a cross-sectional survey of UC patients that was 
conducted between June and September 2014. Patients followed in 
gastroenterology clinics of 38 Spanish hospitals participated in the 
survey. Regarding the size of the participating hospitals, the different 
types that were representative of the network of public hospitals in 
Spain was taken into account (> 900 beds [37%], n = 14; 500-900 
beds [34%], n = 13; < 500 beds [29%], n = 11).
Participants and procedures 
Thirty-nine gastroenterologists handed out the survey to 585 
adult patients with UC. To prevent selection bias, each physician 
handed out the survey consecutively to the first 15 UC patients who 
routinely attended the clinics, irrespective of the severity of the dis-
ease or any other criterion. Patients received instructions to read and 
answer the questionnaire anonymously and voluntarily from their 
home, returning the completed questionnaire by mail in a prepaid 
envelope with the address of the agency in charge of tabulation and 
analysis of the data. No reminder was made to complete the survey 
and the physicians did not collect any data from the patients’ medical 
history. 
Instrument used for the survey 
The UC-LIFE survey was created with the participation of three 
expert physicians in the treatment of inflammatory bowel disease 
(IBD), and was reviewed by three patients belonging to the Con-
federation of Associations for Patients with Crohn’s and Ulcerative 
Colitis of Spain (ACCU) to ensure that the questions and language 
used were appropriate and understandable. The questionnaire con-
sisted of 44 closed and multiple-choice questions that requested 
information about the following aspects: demographic character-
istics, perception of symptom burden and severity of the disease 
during the previous year, social and emotional impact due to UC in 
everyday life, the most important treatment attributes for patients 
and satisfaction with current treatment and physician behaviors’ 
during the medical interview. In addition, questions were included 
about the main information sources for patients, knowledge of the 
disease (through a series of statements which the patients had to 
respond to by agreeing or not with them), frequency of visits to the 
physician in the last year, frequency of routine visits and options for 
access to the specialists in case of a flare-up. The complete survey is 
available as an appendix to the main publication (16).
Statistical considerations
UC-LIFE was a survey of an exploratory nature and no formal 
hypotheses or sample sizes were established. Quantitative variables 
are expressed as mean and standard deviation (SD) or median and 
interquartile range (IQR) if the data did not follow a normal distri-
bution. Qualitative variables are described as frequencies or percent-
ages. Comparisons were made according to the symptom burden 
and interference with everyday life during the previous year, and 
hospitals were stratified by size based on the number of beds: A (> 
900 beds), B (500-900 beds) and C (< 500 beds). Student’s t-test 
was used for simple bivariate comparisons or between independent 
groups. The Chi-squared or Fisher’s exact test were used to com-
pare proportions. Multiple comparisons between subgroups were 
performed using the minimum significant difference test. Missing 
values were not imputed. Given the basically descriptive nature of 
the results, no adjustments for multiplicity were made. A p-value ≤ 
0.05 was considered to be statistically significant. Statistical analysis 
was performed using SPSS software version 18.0.0.
Ethical considerations
The survey was reviewed and approved by the Ethics Committee 
of the Hospital Parc Taulí, Barcelona (Spain), and by the Confedera-
tion of Associations for Patients with Crohn’s and Ulcerative Colitis 
of Spain (ACCU).
The documentation accompanying the survey provided the 
patient with information about the anonymous nature of the survey 
and the pooled processing of the data, thus ensuring that patient 
identification was not possible. Sending of the completed survey by 
the patient was considered as consent to participate.
RESULTS
Demographic characteristics
The survey was handed out to 585 patients and 436 
returned it completed (response rate: 74.5%). By hospital 
size, 35.8% of patients were from large hospitals (> 900 
beds), and 34.8% and 29.4% were from medium (900-
500 beds) and small hospitals (< 500 beds), respectively. 
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The mean age of respondents was 46.2 (SD 13.6) years, 
and 52.8% of them were men. The median duration of the 
disease was eight (IQR: 4-15) years. Demographic charac-
teristics are described in table I. Overall, 47.1% of patients 
indicated that their symptoms had been controlled during 
the previous year, and 28.0% and 24.9%, respectively, 
reported having had “symptoms with no impact on every-
day life” and “symptoms with impact on everyday life”. 
Patients’ information sources and knowledge  
of disease
The most frequently cited information sources by 
patients were the specialist physician (89.2%), web pag-
es specialized in UC (36.9%) and the Primary Care (PC) 
physician (26.7%) (Table II). The vast majority of patients 
indicated the specialist physician as the most important 
source (93.0%). When information sources were analyzed 
by hospital size, patients treated in smaller hospitals men-
tioned more frequently the PC physician and patient asso-
ciations than those treated in larger hospitals (Table II).
Nearly three quarters of patients stated that their physician 
always or nearly always provided them information about 
the causes, the possible course of the disease and the differ-
ent treatment options (70.8%, 69.1% and 72.5%, respec-
tively). The frequency with which patients agreed with each 
of the above statements was significantly higher in smaller 
hospitals compared to medium or large hospitals (Fig. 1).
Based on the correct responses given by patients on spe-
cific statements about UC, the large majority seem to have 
an adequate knowledge of the relapsing and noncontagious 
nature of the disease or the need for lifelong treatment, with 
percentages of 88.2%, 93.2% and 88.2%, respectively. How-
ever, between 32% and 40% of patients showed an erroneous 
belief or no knowledge about aspects related to the incurable 
nature of the disease (32.4%), the role of diet (30.5%) or the 
possibility of involvement of other organs in addition to the 
intestine (40.0%). The areas of knowledge of the disease in 
which a larger percentage marked erroneous responses or 
indicated no knowledge were related to the hereditary nature 
of UC and the role of stress in the origin of the disease, at 
61.6% and 80.4%, respectively.
In the subgroup analysis by hospital size, the percent-
age of patients with correct responses about UC in smaller 
hospitals was generally higher than in medium and large 
hospitals. Specifically, in questions on the incurable nature 
of the disease and the role of diet and stress in the develop-
ment of UC, a significantly higher percentage of patients 
responded correctly in small hospitals compared to large 
hospitals (Fig. 2).
Follow-up in a hospital clinic and access in case  
of flare-up
With regard to the frequency in which patients attend-
ed their specialist clinic during the previous year, 40.6%, 
44.9% and 14.4% attended 0-2 times, 3-5 times and > 
5 times, respectively (n = 394). Almost half of patients 
(47.2%) stated that they agreed with their physician to have 
routine visits every 2-3 months, 36.1% and 14.1% every 
six months or every year, respectively, and only 2.3% did 
not agree on routine visits. 
Patients from smaller hospitals reported a significantly 
higher frequency of routine visits compared to those from 
medium and large hospitals (Table III). According to the 
symptom control reported by patients during the previ-
ous year, the frequency of follow-up in patients whose 
symptoms had been controlled was significantly higher 
in smaller hospitals (Table III.2), whereas patients with 
symptoms in the previous year reported similar frequencies 
of follow-up in large, medium and small hospitals (Table 
III. 3 and 4).
In case of a clinical flare-up, the following options were 
stated by patients: telephone contact (59.6%), possibility 
Table I. Demographic characteristics of participants 
Age (mean ± SD), years 46.2 ± 13.56
Sex, n (%)
Male 229 (52.8)
Female 205 (47.2)
Marital status, 
n (%)
Single 91 (20.9)
Married/unmarried couple 302 (69.4)
Divorced 30 (6.9)
Widow 10 (2.3)
Education, n 
(%)
No schooling 15 (3.5)
Primary Education 130 (30.0)
Secondary Education 85 (19.6)
Vocational training 91 (21.0)
Higher education 109 (25.1)
Other 4 (0.9)
Occupational 
status, n (%)
Student 16 (3.7)
Active worker 228 (52.7)
Housekeeper 47 (10.9)
Retired 51 (11.8)
Unemployed 52 (12.0)
Temporary sick leave due to UC 12 (2.8)
Permanent sick leave due to UC 7 (1.6)
Sick leave for other reasons 9 (2.1)
Other 11 (2.5)
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of getting an appointment in the hospital on the same day 
(36.9%), and having to go to the Emergency Department 
(29.6%). Nearly a quarter of patients (21.0%) stated that 
they had to ask for an appointment and wait until their 
physician was available, and 15.1% said they could get in 
contact by e-mail. Patients from small hospitals reported 
more availability when contacting by phone or e-mail and 
a lower need to ask for an appointment and wait for their 
physician to be available (p < 0.05) (Fig. 3).
DISCUSSION
The present study, based on the results of the UC-LIFE 
survey, complements other two studies which discussed 
different aspects dealt with in the survey about the per-
ception of symptom burden of the disease, preferences 
and satisfaction with treatment (16) and the psychosocial 
impact perceived by the patient (17). This analysis pro-
vides relevant information on the knowledge that patients 
have about important aspects of their disease and about 
their follow-up and access to the gastroenterologist, and 
reveals significant differences in favor of patients who are 
followed in small hospitals.
Ulcerative colitis is a disease that affects all aspects of 
the individual’s life and therefore patient education and 
a collaborative relationship with the physician are key 
aspects in achieving optimum results in terms of control 
of the disease and quality of life of the patient (12,13,18). 
In the UC-LIFE survey, patients highlighted the gastroen-
Table II. Main information sources for patients. Number of patients and percentage of total patients in each type of hospital 
Hospital size
> 900 beds(a) 500-900 beds(b) < 500 beds(c) Total
Specialist physician 119 (87.5) 123 (87.9) 106 (93.0) 348 (89.2)
Web pages specialized in UC 53 (39.0) 52 (37.1) 39 (34.2) 144 (36.9)
PC physician 32 (23.5) 27 (19.3) 45 (39.5)(a)(b) 104 (26.7) 
Nurse 25 (18.4) 24 (17.1) 24 (21.1) 73 (18.7)
Patient associations 22 (16.2) 13 (9.3) 28 (24.6)(b) 63 (16.2)
Patient brochures 21 (15.4) 14 (10.0) 20 (17.5) 55 (14.1)
Friends or relatives 20 (14.7) 18 (12.9) 16 (14.0) 54 (13.8)
Blogs related to UC or health 9 (6.6) 17 (12.1) 15 (13.2) 41 (10.5)
Other patients 16 (11.8) 11 (7.9) 6 (5.3) 33 (8.5)
General media (press, TV, radio) 5 (3.7) 10 (7.1) 9 (7.9) 24 (6.2)
Pharmacist 9 (6.6) 6 (4.3) 3 (2.6) 18 (4.6)
Superscripts indicate that the distribution of the responses is significantly different from the specified group (p < 0.05).
Fig. 1. Patients’ perceptions on the specialist’s behavior during the medi-
cal interview by hospital size. Percentage of patients who responded 
“always” or “almost always” to each of the questions by hospital size. 
Superscripts indicate that the distribution of the responses is significantly 
different from the specified group (p < 0.05).
Fig. 2. Participants’ knowledge of the disease. Percentage of patients 
who responded correctly to the statements by hospital size. Hospitals A 
> 900 beds; hospitals B 900-500 beds; hospitals C < 500 beds. (*) p < 
0.05 vs A; (**) p < 0.05 vs A and B.
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Likewise, Bernstein et al. found similar results in 74 IBD 
patients. In this last study, and in agreement with our 
results, the second most important information source for 
patients was the internet (11). In this regard, the physi-
cian’s advice on adequate and reliable web pages which 
can help patients to improve their knowledge of the disease 
may be particularly useful for them. 
In the present survey, only 19% of patients mentioned nurs-
ing staff as an information source. The reason is probably that 
not all clinics have nursing staff specialized in IBD, a valuable 
resource that has shown to be effective to inform patients about 
general aspects of their disease and enhance adherence to med-
ication. Based on all this, nurses are now a cornerstone in the 
diagnosis and follow-up of these patients (19).
Sixteen percent of respondents considered patient 
associations as an important information source, and this 
percentage was significantly higher in patients treated at 
smaller hospitals (24%). Associations usually offer infor-
mation and emotional support, which are important aspects 
for the patient, so referral of patients to these associations 
may be beneficial for them. 
A significant number of participants seem to have erro-
neous beliefs about some aspects related to UC such as its 
Fig. 3. Patients’ options to contact their physician in case of flare-up 
stratified by hospital size. Superscripts indicate that the distribution of 
the responses is significantly different from the specified group (p < 
0.05).
Table III. Frequency of routine visits by hospital size and according to symptom control and impact on everyday life during 
the previous year, number and percentage
 Hospital size
> 900 beds(a) 500-900 beds(b) < 500 beds(c) Total
1) All patients:
  Every 2-4 months 68 (45.6) 61 (41.8) 67 (56.3)
(a)(b)
196 (47.3)
  Every 6 months 50 (33.6) 57 (39.0) 42 (35.3)
(a)(b)
149 (36.0)
  Every 12 months 27 (18.1) 23 (15.8) 9 (7.6)
(a)(b)
59 (14.3)
  We do not agree with routine visits 4 (2.7) 5 (3.4) 1 (0.8)
(a)(b)
10 (2.4)
2) Patients with controlled symptoms:
  Every 2-4 months 24 (38.7) 27 (39.1) 26 (54.2)
(a)(b)
77 (43.0)
  Every 6 months 23 (37.1) 26 (37.7) 18 (37.5)
(a)(b)
67 (37.4)
  Every 12 months 14 (22.6) 13 (18.8) 4 (8.3)
(a)(b)
31 (17.3)
  We do not agree with routine visits 1 (1.6) 3 (4.3) 0 (0.0)
(a)(b)
4 (2.2)
3) Patients with symptoms not interfering with daily life:
  Every 2-4 months 18 (47.4) 10 (31.3) 15 (48.4) 43 (42.6)
  Every 6 months 13 (34.2) 18 (56.3) 13 (41.9) 44 (43.6)
  Every 12 months 6 (15.8) 4 (12.5) 2 (6.5) 12 11.9)
  We do not agree with routine visits 1 (2.6) 0 (0.0) 1 (3.2) 2 (2.0)
4) Patients with symptoms interfering with daily life:
  Every 2-4 months 19 (59.4) 21 (63.6) 19 (67.9) 59 (63.4)
  Every 6 months 10 (31.3) 7 (21.2) 9 (32.1) 26 (28.0)
  Every 12 months 2 (6.3) 3 (9.1) 0 (0.0) 5 (5.4)
  We do not agree with routine visits 1 (3.1) 2 (6.1) 0 (0.0) 3 (3.2)
Superscripts indicate that the distribution of the responses is significantly different from the specified group (p < 0.05).
terologist as their main information source. Other studies 
have found similar results: the survey carried out by Rubin 
et al. in 451 UC indicated that, for 89% of patients, the 
gastroenterologist was their main information source (6). 
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chronic and incurable nature, transmission to offspring, the 
role of diet or stress on the development of the disease, or 
the possible occurrence of extraintestinal manifestations. 
An interesting finding is that patients treated in smaller 
hospitals seem in general to have a better knowledge of 
many of these aspects.
On the other hand, seven out of ten patients think that 
their physicians always or almost always inform them 
about their disease causes, course and possible treatment 
options, and once again patients most frequently report that 
their physicians deal with these issues in smaller hospitals. 
The extension and difficulty of the aspects to be discussed 
with the patient, especially at the time of the initial diag-
nosis, requires time, which is not always available within 
a routine visit. Therefore, in many cases it may be more 
efficient to schedule additional visits where, in addition to 
the explanations of the medical team, patients’ concerns, 
information needs and opinions can be addressed. In this 
regard, drawing an educational plan that allows patients 
to answer their questions and acquire an adequate knowl-
edge of their disease could be beneficial for most patients 
(10,11).
A patient-centered communication model which con-
siders their opinions, understands their concerns and infor-
mation needs, and takes into account pyschosocial aspects 
related to UC will help patients resolve their symptoms 
and feel more satisfied with the care they receive (10,18). 
In this regard, various studies have shown that educating 
patients to be more autonomous in the management of their 
disease can have a positive impact on the number of visits 
to the physician. Robinson et al. carried out a study in 203 
UC patients in which the intervention group was trained in 
self-management of their UC and only went to the physi-
cian clinic when they thought it was necessary, while the 
control group received no training and followed the normal 
schedule of routine visits. Both groups were followed for 
a median of 14 months (IQR 11-18). In patients from the 
intervention group, treatment of a flare-up of their disease 
was much more rapid and they made significantly fewer 
visits to the hospital and PC physician (20). Kennedy et 
al. obtained similar results, with a reduction in the num-
ber of visits and an increase in patients’ confidence after 
receiving a disease self-management training program 
(21). In line with the results of these studies, the IBD Unit 
of Hospital del Vall d’Hebron carried out a study with 393 
patients who completed a questionnaire on the visits sched-
uling, the need for emergency treatment and the quality 
of the care they received, and were also asked for sugges-
tions on how to improve the control of their disease. Nine-
ty-eight percent of participants thought that information 
and knowledge of their disease could be useful to control 
it and 70% indicated that adequate information could help 
them to start treatment before visiting the physician (22). 
In fact, the reasons for visiting the physician were more 
often related to the patient’s emotional health than to the 
disease itself, and therefore a more patient-centered mod-
el, where patients are appropriately educated about their 
disease and participate more actively in their care, may be 
also beneficial to the healthcare system (23-25).
In this patient sample, nearly half of them had visited 
their specialist physician 3-5 times during the previous 
year, agreeing with him/her on routine visits every 2-3 
months. This frequency was significantly higher in smaller 
hospitals, and it is striking that this higher frequency seems 
to occur in patients who state that their UC is controlled, 
without symptoms. The reasons for this discrepancy cannot 
be deduced from the survey data, but they may be related 
at least in part to a different care load, which in turn deter-
mines the frequency of patient appointments. One consid-
eration in this respect is that certain patients, particularly 
those who reported having been controlled in the last year, 
could be followed more efficiently with fewer visits to 
the hospital. Regarding this, in the CRONICA-UC study, 
the SCCAI questionnaire for UC patients was recently 
validated for its remote use from the patient’s home via 
a web page, with a good correlation to the questionnaire 
evaluated by the physician in the hospital clinic (26). The 
negative predictive value for active disease was very high 
(95%), suggesting that patients in a stable status of the 
disease could benefit from a more flexible follow-up, with 
remote evaluations and fewer visits to the hospital clinic.
Nearly 60% of patients mentioned their possibility 
to contact their physician by phone in case of flare-up, 
and 37% could get an appointment in the hospital on the 
same day. These figures suggest a high availability of the 
specialist, consistent with the importance of being able to 
contact the physician rapidly at the time of a relapse in 
order to optimize treatment as soon as possible. It should 
be noted that in smaller hospitals patients can contact 
their physicians by phone or e-mail more frequently than 
in medium or large hospitals, and that they have to ask for 
an appointment and wait until their physician is available 
less frequently, though there are no differences between 
hospitals regarding their size in terms of the possibility of 
getting a hospital appointment on the same day.
Our study has a number of limitations. First, informa-
tion is collected from the patient’s self-assessment, and 
the findings commented upon should be understood as the 
patients’ perceptions, which are valuable as they reflect 
how patients live their disease. Second, the participants 
reported on an extended time period of one year, and there-
fore their responses may be affected by recall bias. The sur-
vey was handed out to patients followed in hospital clinics, 
therefore, participants in the survey are not necessarily rep-
resentative of the whole population of UC patients. Hand-
ing out the survey to consecutive patients may increase the 
likelihood of including patients with more severe disease, 
who tend to attend the clinics more frequently; however, 
this also reduces patient selection bias by the physicians. 
This fact may partly explain the high frequency of visits 
reported by these patients in the survey (nearly half stated 
being seen every 2-4 months). The survey was distributed 
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in three types of hospitals according to their size, but no 
information was collected on whether the patients came 
from hospitals with IBD units or specialized nurses, which 
could influence the way in which patients are treated or 
followed, and therefore their responses. Finally, the anon-
ymous nature of the survey does not allow us to know the 
profile of the patients who did not return the completed 
questionnaire, and also we do not know what effect the fact 
that the survey period overlapped with the summer period 
has on the selection of the sample. 
In summary, the patients participating in the UC-LIFE 
survey considered the specialist physician as their main 
information source, and their responses suggest that 
knowledge of certain aspects of their disease could be 
improved. The frequency with which patients go to their 
specialist physician, even in a situation of clinical stability, 
and the frequency with which, in case of a flare-up, they 
can be attended by the specialist, either on the same day 
in the hospital or by phone, suggests a notable availability 
of the physicians to their patients. The differences found 
between hospitals of different sizes, where patients from 
small hospitals seem to know their disease better but are 
also seen more frequently and have a better access, should 
be taken into account for the purpose of a more efficient 
planning of the care provided to these patients. 
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